Search
for
Sort by
Research 871–900 of 1000+
- This Week in JAMA
- Fibrosing Alopecia in a Pattern Distribution
- New trends in the treatment of androgenetic alopecia
- UTILIZAÇÃO DE FINASTERIDA NO TRATAMENTO DA HIPERPLASIA PROSTÁTICA BENIGNA – RELATO DE CASO
- ABSTRACTS—SYMPOSIA
- Androgenic alopecia and dutasteride in hair mesotherapy: A short review
- A quantitative hair growth assessment in androgenetic alopecia after application of two cosmetic lotions versus 2% topical minoxidil
- Intracrine Testosterone Activation in Human Pancreatic β-Cells Stimulates Insulin Secretion
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Pathogenesis of androgenetic alopecia
- Frontal Fibrosing Alopecia: A Review
- Male androgenetic alopecia (Part II)
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- 5α-Reductases in Human Physiology: An Unfolding Story
- Safety concerns when using novel medications to treat alopecia
- Frontal fibrosing alopecia: efficacy of treatment modalities
- Saw palmetto and finasteride in the treatment of category-iii prostatitis/chronic pelvic pain syndrome
- Reply to Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice
- Effects of finasteride on the morphology of polycystic ovaries
- Systematic review: interventions in sickle cell disease-related priapism in reducing overall morbidity, recurrence, and side effects
- PREFACE
- Adverse events with finasteride or dutasteride: FAERS
- Dutasteride, finasteride: no increased risk of ED
- Female pattern hair loss
- Revisión actualizada del tratamiento de la alopecia androgenética femenina
- Species Differences in Prostatic Steroid 5<i>α</i>-Reductases of Rat, Dog, and Human
- Androgenetic alopecia in men and women
- Current and Emerging Approaches to Androgenetic Alopecia
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond